Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,731,772
  • Shares Outstanding, K 57,959
  • Annual Sales, $ 18,660 K
  • Annual Income, $ -132,690 K
  • 60-Month Beta 1.50
  • Price/Sales 247.53
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.27
  • Number of Estimates 3
  • High Estimate 0.54
  • Low Estimate -0.70
  • Prior Year -1.69
  • Growth Rate Est. (year over year) +84.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.50 +101.58%
on 06/03/20
89.50 -8.78%
on 06/30/20
+32.00 (+64.46%)
since 06/02/20
3-Month
13.60 +500.29%
on 04/03/20
89.50 -8.78%
on 06/30/20
+67.78 (+489.03%)
since 04/02/20
52-Week
3.54 +2,206.21%
on 11/21/19
89.50 -8.78%
on 06/30/20
+75.97 (+1,339.86%)
since 07/02/19

Most Recent Stories

More News
Novavax Announces Updates to Leadership Team

Frank Czworka appointed SVP, Global Sales

NVAX : 81.64 (+2.43%)
FDA Issues Guidance for Coronavirus Vaccine Developers

Around a dozen companies are developing a vaccine for the deadly coronavirus disease.

JNJ : 140.97 (+0.42%)
AZN : 53.80 (+0.90%)
PFE : 34.51 (+2.28%)
MRK : 78.78 (+0.84%)
MRNA : 58.57 (-4.90%)
NVAX : 81.64 (+2.43%)
3 Top Momentum Stocks for July

DocuSign, Inc. (DOCU), Novavax, Inc. (NVAX), and Inovio Pharmaceuticals, Inc. (INO) are three momentum stocks to keep an eye on in July. Using a momentum investing strategy is one that has proven...

NVAX : 81.64 (+2.43%)
DOCU : 190.99 (+6.72%)
INO : 21.45 (+8.72%)
Watch for Novavax Inc to Potentially Pullback After Gaining 11.96% Yesterday

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $78.70 to a high of $88.97. Yesterday, the shares gained 12.0%, which took the trading range above the 3-day high of $86.50...

NVAX : 81.64 (+2.43%)
Novavax Expands Executive Leadership and Announces Key Promotions

GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...

NVAX : 81.64 (+2.43%)
Top Leveraged ETFs of Last Week

Leveraged gold miners and treasury ETFs gained last week despite a market crash.

MRNA : 58.57 (-4.90%)
NVAX : 81.64 (+2.43%)
TMF : 40.53 (+0.17%)
UBT : 133.30 (+0.29%)
NUGT : 76.14 (-2.20%)
UGLD : 201.36 (+0.86%)
LABU : 60.82 (+1.35%)
JNUG : 109.00 (-1.26%)
INDL : 23.43 (+7.58%)
The Zacks Analyst Blog Highlights: Microvision, Veritone, Remark, Novavax and DCP

The Zacks Analyst Blog Highlights: Microvision, Veritone, Remark, Novavax and DCP

NVAX : 81.64 (+2.43%)
MVIS : 1.4700 (+1.38%)
MARK : 2.36 (+2.61%)
VERI : 15.63 (-4.93%)
DCP : 10.45 (-4.39%)
Growth Investing Leads in 1H: 5 Top ETFs & Stocks

Growth investing took a lead so far this year courtesy of massive money flowing into the economy.

NVAX : 81.64 (+2.43%)
NLS : 9.40 (+0.11%)
IWD : 113.05 (+0.51%)
ADAP : 9.79 (-2.00%)
IZEA : 1.1200 (-0.88%)
VUG : 205.27 (+0.42%)
JKE : 239.33 (+0.52%)
IWF : 195.56 (+0.47%)
MGK : 166.31 (+0.48%)
IWY : 108.74 (+0.47%)
VERI : 15.63 (-4.93%)
JKH : 297.84 (+0.38%)
The Zacks Analyst Blog Highlights: Zoom Video, Quidel, Zscaler, Datadog and Novavax

The Zacks Analyst Blog Highlights: Zoom Video, Quidel, Zscaler, Datadog and Novavax

NVAX : 81.64 (+2.43%)
QDEL : 227.04 (+2.84%)
ZS : 110.21 (-1.17%)
ZM : 261.74 (+1.01%)
DDOG : 89.59 (+0.23%)
Fears of a Second Wave of Coronavirus are Aiding These 5 Stocks

Here we pick five stocks which have potentials to gain in situations if the stock market is hit by the second wave of the coronavirus pandemic.

ERIC : 9.31 (+0.22%)
NVAX : 81.64 (+2.43%)
FTNT : 138.44 (-0.56%)
SFM : 24.90 (-0.12%)
ZM : 261.74 (+1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade NVAX with:

Business Summary

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as...

See More

Key Turning Points

2nd Resistance Point 89.35
1st Resistance Point 85.49
Last Price 81.64
1st Support Level 76.59
2nd Support Level 71.55

See More

52-Week High 89.50
Last Price 81.64
Fibonacci 61.8% 56.66
Fibonacci 50% 46.52
Fibonacci 38.2% 36.38
52-Week Low 3.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar